LIMN, LIMNW · CIK 0001971387 · operating
Liminatus Pharma, Inc. (LIMN) is a biological products, (no diagnostic substances) company incorporated in DE, listed on the Nasdaq. With a market capitalization of $7 million, Liminatus Pharma, Inc. is a micro-cap company. The stock currently trades at $0.24, down 4.86% today, with a 52-week range of $0.21–$33.66.
No 10-K filings found.